Renal Cancer - Results from #2700

TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma. July 2, 2020

Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma. July 1, 2020

To Be or "Node" to Be: Nodal Disease and the Role of Lymphadenectomy in the Treatment of Renal Cell Carcinoma. July 1, 2020

Trigonometric Concept of Fluoroscopy-Guided Percutaneous Renal Access June 30, 2020

Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years. June 30, 2020

Real-world Experience With Sunitinib Treatment in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to Risk Score. June 30, 2020

Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events. June 29, 2020

Predictive Markers of First Line Pazopanib Treatment in Kidney Cancer. June 29, 2020

Results of surgical treatment of inferior vena cava tumor thrombi in renal cell carcinoma. June 26, 2020

Solitary, Late Metastatic Recurrence of Renal Cell Carcinoma to the Pancreas: A Case Report. June 26, 2020

Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma. June 25, 2020

Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma. June 25, 2020

C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma. June 24, 2020

Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma. June 24, 2020

COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer. June 24, 2020

Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation. June 23, 2020

Tivozanib in renal cell carcinoma: a new approach to previously treated disease. June 23, 2020

Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-Free Survival in Post-Nephrectomy High-Risk Loco-Regional RCC: Analysis of the S-TRAC Trial. June 23, 2020

A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal C June 23, 2020

Renal cell carcinoma and COVID-19 pandemia: Management strategies adapted to current practice. June 23, 2020

Page 136 of 457